SLC5A7
MOLECULAR TARGETsolute carrier family 5 member 7
SLC5A7 (solute carrier family 5 member 7) is targeted by 13 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting SLC5A7
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | 2-Chloroadenosine 2-Chloroadenosine. | 1.79 | 5 |
| 2 | Adenosine | 1.79 | 5 |
| 3 | Eszopiclone | 1.39 | 3 |
| 4 | propionylpromazine hydrochloride | 1.39 | 3 |
| 5 | Choline | 1.10 | 2 |
| 6 | Harmaline | 1.10 | 2 |
| 7 | Hexachlorophene | 1.10 | 2 |
| 8 | Ritodrine | 1.10 | 2 |
| 9 | Sertraline | 0.69 | 1 |
| 10 | Choline | 0.69 | 1 |
| 11 | Deoxycholic Acid | 0.69 | 1 |
| 12 | pipemidic acid | 0.69 | 1 |
| 13 | Vecuronium Bromide Monoquaternary homolog of PANCURONIUM. | 0.69 | 1 |
About SLC5A7 as a Drug Target
SLC5A7 (solute carrier family 5 member 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 13 compounds with documented SLC5A7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
SLC5A7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.